BITTER ALMOND: Overview, Uses, Side Effects, Precautions, Interactions, Dosing and Reviews

Overview

Almonds are a familiar type of nut. They can be sweet or bitter, depending on the type of tree that produces them. Sweet almond is produced from one type of almond tree (Prunus amygdalus var. dulcis) and does not contain poisonous chemicals. Bitter almond comes from a different type of almond tree (Prunus amygdalus var. amara) and does contain toxic chemicals.

People use bitter almond for conditions such as stretch marks, spasms, pain, and cough, but there is no good scientific evidence to support these uses. Using bitter almond can also be unsafe.

"Bitter almond" volatile oils can also be produced from other related fruit kernels including apricot (Prunus armeniaca), peach (Prunus persica), and plum (Prunus domestica). Similar to bitter almond, these volatile oils are considered poisonous.

How does it work ?

There is not enough scientific information available to know how bitter almond might work for any medical condition. Bitter almond contains a poisonous chemical called hydrocyanic acid (HCN), which can cause serious side effects.

View References

REFERENCES:

Anonymous. Report by the cancer commission of the California Medical Association: the treatment of cancer with "laetriles". California Med 1953;78(4):320-326.

Araya, E., Rodriguez, A., Rubio, J., Spada, A., Joglar, J., Llebaria, A., Lagunas, C., Fernandez, A. G., Spisani, S., and Perez, J. J. Synthesis and evaluation of diverse analogs of amygdalin as potential peptidomimetics of peptide T. Bioorg.Med Chem Lett. 3-1-2005;15(5):1493-1496. View abstract.

Bhatti RA, Ablin RJ, and Guinan PD. Tumour-associated directed immunity in prostatic cancer: effect of amygdalin. IRCS Med Sci 1981;9(1):19.

Biaglow, J. E. and Durand, R. E. The enhanced radiation response of an in vitro tumour model by cyanide released from hydrolysed amygdalin. Int J Radiat Biol Relat Stud.Phys Chem Med 1978;33(4):397-401. View abstract.

Brown WE, Wood CD, and Smith AN. Sodium cyanide as a cancer chemotherapeutic agent: laboratory and clinical studies. Amer J Obstet Gyn 1960;80(5):907-918.

Gostomski FE. The effects of amygdalin on the Krebs-2 carcinoma in adult and fetal DUB (ICR) mice. Disseration Abstracts International 1978;39(5):2075-B.

Hill, G. J., Shine, T. E., Hill, H. Z., and Miller, C. Failure of amygdalin to arrest B16 melanoma and BW5147 AKR leukemia. Cancer Res 1976;36(6):2102-2107. View abstract.

Khandekar, J. D. and Edelman, H. Studies of amygdalin (laetrile) toxicity in rodents. JAMA 7-13-1979;242(2):169-171. View abstract.

Laster, W. R., Jr. and Schabel, F. M., Jr. Experimental studies of the antitumor activity of amygdalin MF (NSC- 15780) alone and in combination with beta-glucosidase (NSC-128056). Cancer Chemother Rep 1975;59(5):951-965. View abstract.

Lea, M. A. and Koch, M. R. Effects of cyanate, thiocyanate, and amygdalin on metabolite uptake in normal and neoplastic tissues of the rat. J Natl.Cancer Inst. 1979;63(5):1279-1283. View abstract.

Manner HW, DiSanti SJ, Maggio MI, and et al. Amygdalin, vitamin A and enzyme induced regression of murine mammary adenocarcinomas. J Manip Physiol Ther 1978;1(4):246-248.

Milazzo, S., Ernst, E., Lejeune, S., and Schmidt, K. Laetrile treatment for cancer. Cochrane.Database.Syst.Rev 2006;(2):CD005476. View abstract.

Moertel, C. G., Ames, M. M., Kovach, J. S., Moyer, T. P., Rubin, J. R., and Tinker, J. H. A pharmacologic and toxicological study of amygdalin. JAMA 2-13-1981;245(6):591-594. View abstract.

Moertel, C. G., Fleming, T. R., Rubin, J., Kvols, L. K., Sarna, G., Koch, R., Currie, V. E., Young, C. W., Jones, S. E., and Davignon, J. P. A clinical trial of amygdalin (Laetrile) in the treatment of human cancer. N.Engl.J.Med. 1-28-1982;306(4):201-206. View abstract.

Morrone JA. Chemotherapy of inoperable cancer: preliminary report of 10 cases treated with laetrile. J Exper Med Surg 1962;20:299-308.

Navarro MD. Five years experience with laetrile therapy in advanced cancer. Acta Unio Internat Contra Cancrum 1959;15(suppl 1):209-221.

Navarro MD. The Philippine experience in the early detection and chemotherapy of cancer. Santo Tomas J Med 1970;25(3):125-133.

Ovejera, A. A., Houchens, D. P., Barker, A. D., and Venditti, J. M. Inactivity of DL-amygdalin against human breast and colon tumor xenografts in athymic (nude) mice. Cancer Treat.Rep 1978;62(4):576-578. View abstract.

Ross, W. E. Unconventional cancer therapy. Compr.Ther 1985;11(9):37-43. View abstract.

Stock, C. C., Tarnowski, G. S., Schmid, F. A., Hutchison, D. J., and Teller, M. N. Antitumor tests of amygdalin in transplantable animal tumor systems. J Surg Oncol 1978;10(2):81-88. View abstract.

Syrigos, K. N., Rowlinson-Busza, G., and Epenetos, A. A. In vitro cytotoxicity following specific activation of amygdalin by beta-glucosidase conjugated to a bladder cancer-associated monoclonal antibody. Int J Cancer 12-9-1998;78(6):712-719. View abstract.

Wodinsky, I. and Swiniarski, J. K. Antitumor activity of amygdalin MF (NSC-15780) as a single agent and with beta-glucosidase (NSC-128056) on a spectrum of transplantable rodent tumors. Cancer Chemother Rep 1975;59(5):939-950. View abstract.

Chen J, Liu L, Li M, Yu X, Zhang R. An improved method for determination of cyanide content in bitter almond oil. J Oleo Sci. 2018;67(3):289-294. View abstract.

Chronic Conditions Common in Minorities

What Vitamins Do You Need as You Age?

Follow a Healthy Path

Think You Have a Vitamin B12 Deficiency?

CONDITIONS OF USE AND IMPORTANT INFORMATION: This information is meant to supplement, not replace advice from your doctor or healthcare provider and is not meant to cover all possible uses, precautions, interactions or adverse effects. This information may not fit your specific health circumstances. Never delay or disregard seeking professional medical advice from your doctor or other qualified health care provider because of something you have read on WebMD. You should always speak with your doctor or health care professional before you start, stop, or change any prescribed part of your health care plan or treatment and to determine what course of therapy is right for you.

This copyrighted material is provided by Natural Medicines Comprehensive Database Consumer Version. Information from this source is evidence-based and objective, and without commercial influence. For professional medical information on natural medicines, see Natural Medicines Comprehensive Database Professional Version.
© Therapeutic Research Faculty 2020.

VITAMINS & SUPPLEMENTS CENTER

DRUGS AND MEDICATIONS CENTER

FIRST AID RESOURCES

RELATED TO VITAMINS & SUPPLEMENTS

BITTER ALMOND

Overview

How does it work ?

Uses & Effectiveness ?

Insufficient Evidence for

Side Effects

Special Precautions & Warnings:

Special Precautions and Warnings

Interactions ?

Moderate Interaction

Sedative medications (CNS depressants) interacts with BITTER ALMOND

Dosing

You Might Also Like

WebMD Special Sections

Health Solutions

More from WebMD